Mechanisms of TNF-α-induced insulin resistance

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 2, 1999, Pages 119-125

  Hotamisligil, G S ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adipocyte; Cytokines; Insulin action; Obesity; Type 2 diabetes

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; MESSENGER RNA; PROTEIN P55; PROTEIN P75; RECEPTOR; SERINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; DIABETES MELLITUS; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; MOUSE; MUSCLE; NONHUMAN; OBESITY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 0032925340     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212086     Document Type: Conference Paper

References (48)

1. Ahmad F, Goldstein BJ: Effect of tumor necrosis factor-αlpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatase. J Cell Biochem 64: 117-127, 1997
2. Berk PD, Zhou SL, Kiang CL, Stump D, Bradbury M, Isola LM: Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J Biol Chem 272: 8830-8835, 1997
3. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10, 1997
4. Carey JV, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE: Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women - the nurses' health study. Am J Epidemiol 145: 614-619, 1997
5. Caro JF, Sinha MK, Kolacznski JW, Zhamg PL, Considine RV: Leptin: the tale of an obesity gene. Diabetes 45: 1455-1462, 1996
6. Cheung AT, Ree D, Kolls JK, Fuselier J, Coy DH, Bryer-Ash M: An in vivo model for elucidation of the mechanism of TNFα induced insulin resistance: evidence for differential regulation of insulin signaling by TNFα. Endocrinology 1998; 139: 4928-4935
7. Cornelius P, Lee MD, Marlowe M, Pekala PH: Monokine regulation of glucose transporter mRNA in L6 myotubes. Biochem Biophys Res Comm 165: 429-436, 1989
8. Edelstein SL, Knowler WC, Raymond PB, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF: Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46: 701-710, 1997
9. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A: Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268: 26055-26058, 1993
10. Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, Richart C, Soler J: The TNF-alpha gene Neo I polymorphism influences the relationship among insulin resistance, percent body fat and increased serum leptin levels. Diabetes 46: 168-172, 1997
11. Fiedorek FT: Rodent genetic models for obesity and non-insulin-dependent diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM (eds). Diabetes mellitus: a fundamental and clinical text, Lippincott-Raven, Philadelphia, 1996, pp 604-618
12. Guo D, Donner D: Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate-1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 271: 615-618, 1996
13. Hamann A, Benecke H, le Marchand-Brustel Y, Sisulic VS, Lowell BB, Flier JS: Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44: 1266-1273, 1995
14. Hauner H, Petruschke T, Russ M, Eckel J: Effects of tumor necrosis factor-alpha (TNF-Alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 38: 764-771, 1995
15. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM: Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 135: 2279-2282, 1994
16. Hotamisligil GS, Arner P, Caro JF, Atkinson L, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415, 1995
17. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM: Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94: 1543-1549, 1994
18. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor-alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91: 4854-4858, 1994
19. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271: 665-668, 1996
20. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993
21. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor-alpha: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278, 1994
22. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A: Tumor necrosis factor-alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270: 23780-23784, 1995
23. Kanety H, Hemi R, Papa M Z, Karasik A: Tumor necrosis factor alpha-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 271: 8784-8787, 1995
24. Kanety H, Hemi R, Papa M Z, Karasik A: Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin substrate-1. J Biol Chem 271: 9895-9897, 1996
25. Kellerer M, Häring HU: Pathogenesis of insulin resistance - modulation of the insulin signal at receptor level. Diabetes Res Clin Pract 28: S173-S177, 1995
26. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest 95: 2111-2119, 1995
27. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100: 1-6, 1997
28. Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Muhlhofer A, Berti L, Horikosh H, Ullrich A, Haring H: Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 97: 1471-1477, 1996
29. Lang CH, Dobrescu C, Bagby GJ: Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130: 43-52, 1992
30. Liu LS, Spelleken M, Rohrig K, Hauner H, Eckel J: Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes - implication of the P80 tumor necrosis factor receptor. Diabetes 47: 515-522, 1998
31. Maddux BA. Sbraccia P, Kuymakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, Finegold I: Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373: 448-451, 1995.
32. Moller DE, Fliers JS: Insulin resistance: mechanisms, syndromes and implications. N Engl J Med 325: 938-948, 1992
33. Norman RA, Bogardus C, Ravussin E: Linkage between obesity and a marker near the tumor necrosis factor-a locus in Pima Indians. J Clin Invest 96: 158-162, 1995
34. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effects of an engineered human anti-TNFa antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45: 881-885, 1996
35. Ohsumi J, Sakakibara S, Yamaguchi J, Miyadai K, Yoshioka S, Fujiwara T, Horikoshi H, Serizawa N: Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology 135: 2279-2282, 1994
36. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM: Tumor necrosis factor (TNF)-alpha inhibits insulin signalling through stimulation of the P55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271: 13018-13022, 1996
37. Peraldi P, Xu M, Spiegelman BM: Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. J Clin Invest 100: 1863-1869, 1997
38. Remesar X, Rafecas I, Fernandez-Lopez JA, Alemany M: Is leptin an insulin counter-regulatory hormone? FEBS Letters 402: 9-11, 1997
39. Reynet C, Khan CR: Rad: a member of the RAS family overexpressed in muscle of type II diabetic humans. Science 262: 1441-1444, 1993
40. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNF( by human muscle: relationship to insulin resistance. J Clin Invest 97: 1111-1116, 1996
41. Stephens JM, Pekala PH: Transcription repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 266: 21839-21845, 1991
42. Stephens JM, Lee JL, Pilch PF: Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and glut4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272: 971-976, 1997
43. Tartaglia LA, Goeddel DV: Two TNF receptors. Immun Today 13: 151-153, 1992
44. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610-614, 1997
45. Uysal KT, Wiesbrock SM, Hotamisligil GS: Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 139: 4832-4838, 1998
46. van der Pol T, Romijn JA, Endert E, Borm JJ, Büller HR, Sauerwein HP: TNF mimics the metabolic response of acute infections in healthy humans. Am J Physiol 261: E457-E465, 1991
47. Ventre J, Doebber T Wu M, Macnaul K, Stevens K, Pasparakis M, Kollias G, Moller DE: Targeted disruption of the tumor necrosis factor-alpha gene - metabolic consequences in obese and non-obese mice. Diabetes 46: 1526-1531, 1997
48. Yamakawa T, Tanaka S, Yamakawa Y, Kiuchi Y, Isoda F, Kawamoto S, Okuda K, Sekihara H: Augmented production of tumor necrosis factor-alpha in obese mice. Clin Immun & Immunopath 75: 51-56, 1995